Cha Meditech | Revive NX Ltd

Revive NX Ltd is the UK and Ireland division of Cha Meditech, bringing one of the most advanced regenerative aesthetics portfolios into clinical practice.

We specialise in results that go beyond traditional treatment models, focusing on skin quality, longevity, and truly undetectable outcomes. Our approach combines cutting-edge biotechnology with structured protocols designed not only to improve results but to transform how practitioners work in the clinic.

Our portfolio includes Celltermi Revive NX Exosomes with patented Nidogen-1, advanced PCL collagen biostimulation, and next-generation skin solutions, all delivered through our Revive 5-Step Rejuvenation Roadmap™. This is a complete system built to create consistent, refined outcomes while supporting long-term patient satisfaction and retention.

What sets us apart is not just what we offer, but how we teach it.

Through our Longevity Institute, the only one of its kind in the UK, we provide CPD education, clinical guidance, and real-world business strategies that help practitioners turn knowledge into a thriving, scalable clinic. We bridge the gap between treatment and commercial success, ensuring our partners not only deliver better results but also build stronger, more profitable businesses.

At Aesthetic Medicine London, we are showcasing how regenerative aesthetics should be delivered, with live demonstrations, real protocols, and a clear pathway for those ready to move beyond traditional approaches.

Visit us at Stand E50 and experience the next level of aesthetic practice.